Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases

Fatema Amatur Rahman1, Imin Wushur1, Ida Kristine Østnes Hansen2

  • 1Pharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.

Plos One
|August 1, 2025
PubMed

Insights

Developing novel inhibitors against bacterial resistance is crucial. This study investigated bacterial and human zinc metalloproteases (MPs) using molecular dynamics and inhibition studies, revealing the S1

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Bacterial resistance necessitates novel therapeutic strategies, such as targeting bacterial virulence factors.
  • Bacterial zinc metalloproteases (MPs) are key virulence factors that share structural similarities with human MPs.
  • Understanding the binding interactions of bacterial and human MPs is essential for developing selective inhibitors.

Purpose of the Study:

  • To investigate the molecular interactions and cleavage patterns of thermolysin (TLN), a bacterial MP, with a model substrate.
  • To evaluate the inhibitory potential of phosphinyl-containing compounds against bacterial (TLN, PLN, ALN) and human (MMP-9, MMP-14) MPs.
  • To elucidate the structural determinants of inhibitor selectivity between bacterial and human zinc MPs.

Main Methods:

  • Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) for analyzing substrate cleavage.
  • Molecular dynamics (MD) simulations to model enzyme-substrate interactions.
  • Enzyme inhibition kinetic studies and induced fit docking to assess compound efficacy and binding modes.

Main Results:

  • MALDI-TOF MS identified three cleavage sites on the substrate by TLN, with preferential cleavage between Ala-Phe and Gly-Phe.
  • MD simulations correlated substrate-enzyme interactions with observed cleavage patterns, highlighting the role of the S1' subpocket.
  • Compound H-1 showed selectivity for human MMPs over bacterial MPs due to steric hindrance in the bacterial S1' subpocket.
  • Compound H-2 exhibited inhibitory activity against both bacterial and human MPs, with distinct binding interactions.

Conclusions:

  • The size of the S1' subpocket significantly influences inhibitor selectivity between bacterial and human zinc MPs.
  • Phosphinyl-containing compounds demonstrate potential as inhibitors, with structural modifications guiding selectivity.
  • Further research into selective MP inhibition can aid in combating bacterial resistance and off-target effects.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.6K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
82.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
Introduction to Mechanisms of Enzyme Catalysis01:13

Introduction to Mechanisms of Enzyme Catalysis

For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
8.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.3K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
280